Tapewire

Nasdaq · USD

LGND

LIGAND PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
3825
SEC CIK
0000886163
Parsed reports
442

Last 12 months

Inside the activity.

0 purchase rows · 131 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202508
Dec 202508
Jan 202605
Feb 202605
Mar 2026032
Apr 2026011
May 2026014
Jun 2026016
Jul 202608
Aug 2026012
Sep 202606
Oct 202606

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 14, 2024 Filed May 15, 2024 23:34 UTC
Korenberg Matthew EPresident & Chief Operating
SaleCommon Stock 520 $85.68 $44,555.73
Disclosure

SEC source: 0002001011-24-000052 · edgardoc.xml · nonDerivative · entry 3

Korenberg Matthew E · CIK 0001649903 · President & Chief Operating

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,263

F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $85.6250 to $85.7650. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 14, 2024 Filed May 15, 2024 23:34 UTC
Korenberg Matthew EPresident & Chief Operating
SaleCommon Stock 13,638 $85.08 $1,160,356.50
Disclosure

SEC source: 0002001011-24-000052 · edgardoc.xml · nonDerivative · entry 2

Korenberg Matthew E · CIK 0001649903 · President & Chief Operating

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,783

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $84.5950 to $85.5500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 13, 2024 Filed May 15, 2024 23:34 UTC
Korenberg Matthew EPresident & Chief Operating
SaleCommon Stock 3,440 $84.54 $290,828.26
Disclosure

SEC source: 0002001011-24-000052 · edgardoc.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · President & Chief Operating

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,421

F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $84.5000 to $84.8750. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 09, 2024 Filed May 13, 2024 21:32 UTC
Reardon AndrewChief Legal Officer &
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $52.27 $0.00
Disclosure

SEC source: 0002001011-24-000051 · edgardoc.xml · derivative · entry 3

Reardon Andrew · CIK 0001950232 · Chief Legal Officer &

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,944

Underlying: Common Stock · 10,000 shares

Expires 2032-08-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vests and is exercisable as to 12.5% of the underlying shares on February 1, 2023, and in 42 substantially equal monthly installments thereafter.

Read SEC document
May 09, 2024 Filed May 13, 2024 21:32 UTC
Reardon AndrewChief Legal Officer &
SaleCommon Stock 10,000 $83.04 $830,449.00
Disclosure

SEC source: 0002001011-24-000051 · edgardoc.xml · nonDerivative · entry 2

Reardon Andrew · CIK 0001950232 · Chief Legal Officer &

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,205

F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $83.00 to $83.27. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 09, 2024 Filed May 13, 2024 21:32 UTC
Reardon AndrewChief Legal Officer &
Exercise / conversionCommon Stock 10,000 $52.27 $522,700.00
Disclosure

SEC source: 0002001011-24-000051 · edgardoc.xml · nonDerivative · entry 1

Reardon Andrew · CIK 0001950232 · Chief Legal Officer &

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,205

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 09, 2024 Filed May 18, 2024 00:00 UTC SaleCommon Stock 934 $83.20 $77,713.38
Disclosure

SEC source: 0002001011-24-000054 · edgardoc.xml · nonDerivative · entry 1

Gray Nancy Ryan · CIK 0001714949 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,633

F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $83.1100 to $83.2650. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 30, 2024 Filed May 2, 2024 22:07 UTC
Aryeh JasonDirector
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 2,406 $0.00 Strike: $52.30 $0.00
Disclosure

SEC source: 0002001011-24-000050 · edgardoc.xml · derivative · entry 4

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,406 shares

Expires 2025-04-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This Option was previously reported as a Grant of 2,754 shares, which vested in full on April 24, 2016, at an exercise price of $89.75 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer.

Read SEC document
April 30, 2024 Filed May 2, 2024 22:07 UTC
Aryeh JasonDirector
Exercise / conversionCommon Stock 2,406 $52.30 $125,833.80
Disclosure

SEC source: 0002001011-24-000050 · edgardoc.xml · nonDerivative · entry 1

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,828

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 24, 2024 Filed Apr 26, 2024 22:35 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 2,893 $0.00 Strike: $39.35 $0.00
Disclosure

SEC source: 0002001011-24-000048 · edgardoc.xml · derivative · entry 2

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,893 shares

Expires 2024-06-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This Option was previously reported as a Grant of 3,312 shares, which vested in full on April 24, 2015, at an exercise price of $67.53 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer.

Read SEC document
April 24, 2024 Filed Apr 26, 2024 22:35 UTC Exercise / conversionCommon Stock 2,893 $39.35 $113,839.55
Disclosure

SEC source: 0002001011-24-000048 · edgardoc.xml · nonDerivative · entry 1

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,523

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 21:47 UTC
Davis Todd CDirector · Chief Executive Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 2,156 $0.00 Strike: $68.51 $0.00
Disclosure

SEC source: 0002001011-24-000035 · edgardoc.xml · derivative · entry 8

Davis Todd C · CIK 0001392029 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,156 shares

Expires 2030-06-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This Option was previously reported as a Grant of 2,468 shares, which vested in full on June 4, 2021, at an exercise price of $117.58 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 21:47 UTC
Davis Todd CDirector · Chief Executive Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 2,855 $0.00 Strike: $67.24 $0.00
Disclosure

SEC source: 0002001011-24-000035 · edgardoc.xml · derivative · entry 7

Davis Todd C · CIK 0001392029 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,855 shares

Expires 2031-06-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This Option was previously reported as a Grant of 3,269 shares, which vested in full on June 4, 2022, at an exercise price of $115.39 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 21:47 UTC
Davis Todd CDirector · Chief Executive Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 3,556 $0.00 Strike: $66.19 $0.00
Disclosure

SEC source: 0002001011-24-000035 · edgardoc.xml · derivative · entry 6

Davis Todd C · CIK 0001392029 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,556 shares

Expires 2029-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This Option was previously reported as a Grant of 4,071 shares, which vested in full on June 9, 2020, at an exercise price of $113.59 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 21:47 UTC
Davis Todd CDirector · Chief Executive Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 7,448 $0.00 Strike: $46.20 $0.00
Disclosure

SEC source: 0002001011-24-000035 · edgardoc.xml · derivative · entry 5

Davis Todd C · CIK 0001392029 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,448 shares

Expires 2032-06-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This Option was previously reported as a Grant of 4,340 shares at an exercise price of $79.29 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer, then vested in full on June 10, 2023.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 21:47 UTC
Davis Todd CDirector · Chief Executive Officer
Exercise / conversionCommon Stock 3,556 $66.19 $235,371.64
Disclosure

SEC source: 0002001011-24-000035 · edgardoc.xml · nonDerivative · entry 4

Davis Todd C · CIK 0001392029 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,160

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 21:47 UTC
Davis Todd CDirector · Chief Executive Officer
Exercise / conversionCommon Stock 2,156 $68.51 $147,707.56
Disclosure

SEC source: 0002001011-24-000035 · edgardoc.xml · nonDerivative · entry 3

Davis Todd C · CIK 0001392029 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,604

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 21:47 UTC
Davis Todd CDirector · Chief Executive Officer
Exercise / conversionCommon Stock 2,855 $67.24 $191,970.20
Disclosure

SEC source: 0002001011-24-000035 · edgardoc.xml · nonDerivative · entry 2

Davis Todd C · CIK 0001392029 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,448

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 21:47 UTC
Davis Todd CDirector · Chief Executive Officer
Exercise / conversionCommon Stock 7,448 $46.20 $344,097.60
Disclosure

SEC source: 0002001011-24-000035 · edgardoc.xml · nonDerivative · entry 1

Davis Todd C · CIK 0001392029 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,593

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 05, 2024 Filed Mar 6, 2024 22:28 UTC
Aryeh JasonDirector
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 2,893 $0.00 Strike: $39.35 $0.00
Disclosure

SEC source: 0002001011-24-000032 · edgardoc.xml · derivative · entry 4

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,893 shares

Expires 2024-06-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This Option was previously reported as a Grant of 3,312 shares, which vested in full on April 24, 2015, at an exercise price of $67.53 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer.

Read SEC document
March 05, 2024 Filed Mar 6, 2024 22:28 UTC
Aryeh JasonDirector
Exercise / conversionCommon Stock 2,893 $39.35 $113,839.55
Disclosure

SEC source: 0002001011-24-000032 · edgardoc.xml · nonDerivative · entry 1

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,422

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 18:27 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 2,893 $0.00 Strike: $67.53 $0.00
Disclosure

SEC source: 0001104659-24-031806 · tm248239-1_4seq1.xml · derivative · entry 3

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 419

Underlying: Common Stock · 2,893 shares

Expires 2024-06-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These securities, as represented in Column 5, were acquired by a grant of 3,312 shares by the Board of Directors of the Company at the 2014 Meeting. That grant vested in full on the first anniversary of the grant date or immediately (x) upon a change in control or a hostile takeover of the Company or (y) the death or permanent disability of the grantee if still serving at that time.

F3 · security: This Option was previously reported on the Form 4 filed 6/6/14 as a Grant of 3,312 shares, which vested in full on April 24, 2015, at an exercise price of $67.53 per share, but was adjusted pursuant to the OmniAb Inc. separation from the Issuer.

F2 · derivative.exercise_date: These securities, as represented in Column 5, were acquired by a grant of 3,312 shares by the Board of Directors of the Company at the 2014 Meeting. That grant vested in full on the first anniversary of the grant date or immediately (x) upon a change in control or a hostile takeover of the Company or (y) the death or permanent disability of the grantee if still serving at that time.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 18:27 UTC SaleCommon Stock 1,893 $74.30 $140,649.90
Disclosure

SEC source: 0001104659-24-031806 · tm248239-1_4seq1.xml · nonDerivative · entry 2

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,926

F1 · security: These securities, as represented in Column 5, include a grant of 1,142 restricted share units approved by the Board of Directors of the Company at the 2023 Meeting, which shares will vest in full on the earlier of (a) the date of the next annual meeting of the Company stockholders following the grant date or (b) on the first anniversary of the grant date. They also properly reflect adjustments from the OmniAb Inc. separation from the Issuer. The Shares referenced in Column 5 of Table I as disposed of on the Form 4 filed 5/10/23 for this Reporting Person inadvertently failed correctly to reflect those adjustments. That number should have been 26,784.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 18:27 UTC Exercise / conversionCommon Stock 2,893 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-031806 · tm248239-1_4seq1.xml · nonDerivative · entry 1

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,819

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities, as represented in Column 5, include a grant of 1,142 restricted share units approved by the Board of Directors of the Company at the 2023 Meeting, which shares will vest in full on the earlier of (a) the date of the next annual meeting of the Company stockholders following the grant date or (b) on the first anniversary of the grant date. They also properly reflect adjustments from the OmniAb Inc. separation from the Issuer. The Shares referenced in Column 5 of Table I as disposed of on the Form 4 filed 5/10/23 for this Reporting Person inadvertently failed correctly to reflect those adjustments. That number should have been 26,784.

Read SEC document
February 28, 2024 Filed Feb 29, 2024 23:50 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 325 $0.00 Strike: $58.49 $0.00
Disclosure

SEC source: 0002001011-24-000028 · edgardoc.xml · derivative · entry 8

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,607

Underlying: Common Stock · 325 shares

Expires 2027-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
February 28, 2024 Filed Feb 29, 2024 23:50 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 140 $0.00 Strike: $57.22 $0.00
Disclosure

SEC source: 0002001011-24-000028 · edgardoc.xml · derivative · entry 7

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,722

Underlying: Common Stock · 140 shares

Expires 2030-10-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: As per the separation of OmniAb Inc. from the issuer, 4,096 stock options were vested and exercisable as of November 1, 2022, whereas 3,766 options vest in 23 substantially equal monthly installments beginning on December 1, 2022.

Read SEC document
February 28, 2024 Filed Feb 29, 2024 23:50 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 799 $0.00 Strike: $55.75 $0.00
Disclosure

SEC source: 0002001011-24-000028 · edgardoc.xml · derivative · entry 6

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,869

Underlying: Common Stock · 799 shares

Expires 2030-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: As per the separation of OmniAb Inc. from the issuer, 2,039 stock options were vested and exercisable as of November 1, 2022, whereas 1,629 options vest in 16 substantially equal monthly installments beginning on November 13, 2022.

Read SEC document
February 28, 2024 Filed Feb 29, 2024 23:50 UTC
Espinoza OctavioChief Financial Officer
SaleCommon Stock 140 $88.46 $12,384.40
Disclosure

SEC source: 0002001011-24-000028 · edgardoc.xml · nonDerivative · entry 5

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,755

Read SEC document
February 28, 2024 Filed Feb 29, 2024 23:50 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionCommon Stock 325 $58.49 $19,009.25
Disclosure

SEC source: 0002001011-24-000028 · edgardoc.xml · nonDerivative · entry 4

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,895

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 28, 2024 Filed Feb 29, 2024 23:50 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionCommon Stock 140 $57.22 $8,010.80
Disclosure

SEC source: 0002001011-24-000028 · edgardoc.xml · nonDerivative · entry 3

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,570

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 28, 2024 Filed Feb 29, 2024 23:50 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionCommon Stock 799 $55.75 $44,544.25
Disclosure

SEC source: 0002001011-24-000028 · edgardoc.xml · nonDerivative · entry 2

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,430

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 23:50 UTC
Reardon AndrewCHIEF LEGAL OFFICER &
GrantEmployee Stock Option (right to buy) · Derivative 29,272 $0.00 Strike: $89.20 $0.00
Disclosure

SEC source: 0002001011-24-000030 · edgardoc.xml · derivative · entry 2

Reardon Andrew · CIK 0001950232 · CHIEF LEGAL OFFICER &

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,272

Underlying: Common Stock · 29,272 shares

Expires 2034-02-27

F2 · derivative.exercise_date: The Stock Option grant vests and is exercisable as to 12.5% of the underlying shares 6 months after the grant date, and in 42 substantially equal monthly installments thereafter.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 23:50 UTC
Reardon AndrewCHIEF LEGAL OFFICER &
GrantCommon Stock 7,208 $0.00 $0.00
Disclosure

SEC source: 0002001011-24-000030 · edgardoc.xml · nonDerivative · entry 1

Reardon Andrew · CIK 0001950232 · CHIEF LEGAL OFFICER &

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,205

F1 · shares: Represents Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest over three years, in three substantially equal annual installments on February 15, 2025; February 15, 2026; and February 15, 2027, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 23:50 UTC
Korenberg Matthew EPRESIDENT & CHIEF OPERATING
GrantEmployee Stock Option (right to buy) · Derivative 58,544 $0.00 Strike: $89.20 $0.00
Disclosure

SEC source: 0002001011-24-000029 · edgardoc.xml · derivative · entry 2

Korenberg Matthew E · CIK 0001649903 · PRESIDENT & CHIEF OPERATING

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,544

Underlying: Common Stock · 58,544 shares

Expires 2034-02-27

F2 · derivative.exercise_date: The Stock Option grant vests and is exercisable as to 12.5% of the underlying shares 6 months after the grant date, and in 42 substantially equal monthly installments thereafter.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 23:50 UTC
Korenberg Matthew EPRESIDENT & CHIEF OPERATING
GrantCommon Stock 14,416 $0.00 $0.00
Disclosure

SEC source: 0002001011-24-000029 · edgardoc.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · PRESIDENT & CHIEF OPERATING

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,861

F1 · shares: Represents Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest over three years, in three substantially equal annual installments on February 15, 2025; February 15, 2026; and February 15, 2027, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 23:50 UTC
Espinoza OctavioChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 29,272 $0.00 Strike: $89.20 $0.00
Disclosure

SEC source: 0002001011-24-000028 · edgardoc.xml · derivative · entry 9

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,272

Underlying: Common Stock · 29,272 shares

Expires 2034-02-27

F5 · derivative.exercise_date: The Stock Option grant vests and is exercisable as to 12.5% of the underlying shares 6 months after the grant date, and in 42 substantially equal monthly installments thereafter.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 23:50 UTC
Espinoza OctavioChief Financial Officer
GrantCommon Stock 7,208 $0.00 $0.00
Disclosure

SEC source: 0002001011-24-000028 · edgardoc.xml · nonDerivative · entry 1

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,631

F1 · shares: Represents Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest over three years, in three substantially equal annual installments on February 15, 2025; February 15, 2026; and February 15, 2027, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 23:49 UTC
Davis Todd CDirector · CHIEF EXECUTIVE OFFICER
GrantEmployee Stock Option (right to buy) · Derivative 131,723 $0.00 Strike: $89.20 $0.00
Disclosure

SEC source: 0002001011-24-000027 · edgardoc.xml · derivative · entry 2

Davis Todd C · CIK 0001392029 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,723

Underlying: Common Stock · 131,723 shares

Expires 2034-02-27

F2 · derivative.exercise_date: The Stock Option grant vests and is exercisable as to 12.5% of the underlying shares 6 months after the grant date, and in 42 substantially equal monthly installments thereafter.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 23:49 UTC
Davis Todd CDirector · CHIEF EXECUTIVE OFFICER
GrantCommon Stock 32,436 $0.00 $0.00
Disclosure

SEC source: 0002001011-24-000027 · edgardoc.xml · nonDerivative · entry 1

Davis Todd C · CIK 0001392029 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,145

F1 · shares: Represents Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest over three years, in three substantially equal annual installments on February 15, 2025; February 15, 2026; and February 15, 2027, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Read SEC document
February 15, 2024 Filed Feb 17, 2024 01:10 UTC
Reardon AndrewCHIEF LEGAL OFFICER &
Tax withholdingCommon Stock 593 $74.65 $44,267.45
Disclosure

SEC source: 0002001011-24-000019 · edgardoc.xml · nonDerivative · entry 1

Reardon Andrew · CIK 0001950232 · CHIEF LEGAL OFFICER &

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,997

F1 · shares: Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.

Read SEC document
February 15, 2024 Filed Feb 17, 2024 01:10 UTC
Korenberg Matthew EPRESIDENT & CHIEF OPERATING
Tax withholdingCommon Stock 4,778 $74.65 $356,677.70
Disclosure

SEC source: 0002001011-24-000018 · edgardoc.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · PRESIDENT & CHIEF OPERATING

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,445

F1 · shares: Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.

Read SEC document
February 15, 2024 Filed Feb 17, 2024 01:10 UTC
Espinoza OctavioChief Financial Officer
Tax withholdingCommon Stock 1,479 $74.65 $110,407.35
Disclosure

SEC source: 0002001011-24-000017 · edgardoc.xml · nonDerivative · entry 1

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,423

F1 · shares: Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.

Read SEC document
February 15, 2024 Filed Feb 17, 2024 01:10 UTC
Davis Todd CDirector · CHIEF EXECUTIVE OFFICER
Tax withholdingCommon Stock 1,381 $74.65 $103,091.65
Disclosure

SEC source: 0002001011-24-000016 · edgardoc.xml · nonDerivative · entry 1

Davis Todd C · CIK 0001392029 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,709

F1 · shares: Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:07 UTC
Korenberg Matthew EPRESIDENT & CHIEF OPERATING
Tax withholdingCommon Stock 2,917 $72.31 $210,928.27
Disclosure

SEC source: 0002001011-24-000009 · edgardoc.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · PRESIDENT & CHIEF OPERATING

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,223

F1 · shares: Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.

Read SEC document
December 29, 2023 Filed Jan 4, 2024 21:07 UTC
Reardon AndrewCHIEF LEGAL OFFICER &
OtherCommon Stock 179 $60.71 $10,866.55
Disclosure

SEC source: 0002001011-24-000010 · edgardoc.xml · nonDerivative · entry 1

Reardon Andrew · CIK 0001950232 · CHIEF LEGAL OFFICER &

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,590

F1 · kind: Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c).

Read SEC document
December 05, 2023 Filed Dec 6, 2023 20:27 UTC
Korenberg Matthew EPRESIDENT & CHIEF OPERATING
Tax withholdingCommon Stock 1,984 $59.61 $118,266.24
Disclosure

SEC source: 0002001011-23-000003 · edgardoc.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · PRESIDENT & CHIEF OPERATING

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,140

F1 · shares: Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.

Read SEC document
December 05, 2023 Filed Dec 6, 2023 20:27 UTC
Espinoza OctavioChief Financial Officer
Tax withholdingCommon Stock 1,269 $59.61 $75,645.09
Disclosure

SEC source: 0002001011-23-000004 · edgardoc.xml · nonDerivative · entry 1

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,902

F1 · shares: Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.

Read SEC document
October 01, 2023 Filed Oct 3, 2023 20:36 UTC
Espinoza OctavioChief Financial Officer
Tax withholdingCommon Stock 346 $59.92 $20,732.32
Disclosure

SEC source: 0000886163-23-000073 · edgardoc.xml · nonDerivative · entry 1

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,171

F1 · shares: Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.

Read SEC document
September 22, 2023 Filed Sep 25, 2023 20:44 UTC
Davis Todd CDirector · CHIEF EXECUTIVE OFFICER
PurchaseCommon Stock 4,000 $59.38 $237,528.80
Disclosure

SEC source: 0000886163-23-000057 · edgardoc.xml · nonDerivative · entry 1

Davis Todd C · CIK 0001392029 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,090

F1 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $58.975 to $59.930. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
September 22, 2023 Filed Sep 26, 2023 20:41 UTC GrantEmployee Stock Option (right to buy) · Derivative 11,345 $0.00 Strike: $59.08 $0.00
Disclosure

SEC source: 0000886163-23-000069 · edgardoc.xml · derivative · entry 2

Zimmermann Martine · CIK 0001994049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,345

Underlying: Common Stock · 11,345 shares

Expires 2033-09-22

F2 · derivative.exercise_date: Grant of Stock Options that will vest and become exercisable in three substantially equal annual installments on September 22, 2024; September 22, 2025; and September 22, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.